J Korean Soc Menopause.  2012 Aug;18(2):75-80.

Omega-3 and Menopause

• Kim TH
• Byun DW
• Park Y

Abstract

Menopause is a turning point in women that is based on the sex hormone change. Many women are very conscious about the postmenopausal period. After menopause, women complain about vasomotor symptoms, night sweat, psychological problems, osteoporosis, cardiovascular disease and urogenital symptoms. Nowadays, food and alternative treatment for postmenopausal symptoms are introduced. The average life span is now increasing, and postmenopausal care is important for public health. Long chain omega-3 and omega-6 fatty acids are known as essential fatty acids, however, all mammals, including humans, should obtain them from their diet. Omega-3 fatty acids have emerged as an adjuvant and alternative source for relieving postmenopusal complains or disease. Among alternative treatment or food behavior change for postmenopusal symptoms, we will review the current issues on the relationship between the role and the effect of omega-3 fatty acids in relieving postmenopausal symptoms.

Keyword

Female; Menopause; Omega-3 fatty acids; Omega-6 fatty acids

MeSH Terms

Cardiovascular Diseases
Diet
Fatty Acids, Essential
Fatty Acids, Omega-3
Fatty Acids, Omega-6
Female
Humans
Mammals
Menopause
Osteoporosis
Postmenopause
Public Health
Sweat
Fatty Acids, Essential
Fatty Acids, Omega-3
Fatty Acids, Omega-6

Reference

1. Korean Statistical Information Service. Complete life tables. 2010. cited by 2012 Jun 4. Daejeon: Statistics Korea;Available from: http://kosis.kr/abroad/abroad_01List.jsp?parentId=A.

2. Korean Statistical Information Service. Deaths by city & province/cause (50 item)/by sex. 2010. cited by 2012 Jun 4. Daejeon: Statistics Korea;Available from: http://kosis.kr/abroad/abroad_01List.jsp?parentId=A.

3. Cho MK, Park HM. The national use of hormonal therapy in postmenopausal women in 2010. J Korean Soc Menopause. 2011. 17:150–154.

4. Kim DK, Shin JA, Lee KT. Monitoring of compositions of gamma-linolenic and omega-3 fatty acids in some functional foods consumed in market. CNU J Agric Sci. 2011. 38:277–284.

5. Park JS. Maternal and paternal nutrition before conception. J Korean Med Assoc. 2011. 54:818–824.

6. Park Y. Omega-3 index as a risk factor for cardiovascular disease and its application to Korean population. Korean J Obes. 2010. 19:1–8.

7. Yeoum SG. The investigation on the risk factors of cardiovascular disease for postmenopausal women over 50 years. J Korean Soc Menopause. 2003. 9:266–272.

8. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation. 2004. 109:2705–2711.

9. Park S, Park Y. Effects of dietary fish oil and trans fat on rat aorta histopathology and cardiovascular risk markers. Nutr Res Pract. 2009. 3:102–107.

10. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995. 274:1363–1367.

11. Harris WS, Park Y, Isley WL. Cardiovascular disease and long-chain omega-3 fatty acids. Curr Opin Lipidol. 2003. 14:9–14.

12. Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004. 39:212–220.

13. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002. 346:1113–1118.

14. Chung HY. Osteoporosis diagnosis and treatment 2007. J Korean Endocr Soc. 2008. 23:76–108.

15. So H, Ahn S, Song R, Kim H. Relationships among obesity, bone mineral density, and cardiovascular risks in post-menopausal women. Korean J Women Health Nurs. 2010. 16:224–233.

16. Yoo YW, Lee EN. The Influencing factors of the compliance level with therapeutic regimen after the bone mineral densitometry. J Korean Acad Nurs. 2004. 34:63–71.

17. Haag M, Magada ON, Claassen N, Bohmer LH, Kruger MC. Omega-3 fatty acids modulate ATPases involved in duodenal Ca absorption. Prostaglandins Leukot Essent Fatty Acids. 2003. 68:423–429.

18. Claassen N, Potgieter HC, Seppa M, Vermaak WJ, Coetzer H, Van Papendorp DH, et al. Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: effects on free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content. Bone. 1995. 16:385S–392S.

19. Kruger MC, Coetzer H, de Winter R, Claassen N. Eicosapentaenoic acid and docosahexaenoic acid supplementation increases. Nutr Res. 1995. 15:211–219.

20. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res. 2003. 18:1206–1216.

21. Sakaguchi K, Morita I, Murota S. Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats. Prostaglandins Leukot Essent Fatty Acids. 1994. 50:81–84.

22. Mollard RC, Gillam ME, Wood TM, Taylor CG, Weiler HA. (n-3) fatty acids reduce the release of prostaglandin E2 from bone but do not affect bone mass in obese (fa/fa) and lean Zucker rats. J Nutr. 2005. 135:499–504.

23. Watkins BA, Li Y, Seifert MF. Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats. J Nutr Biochem. 2006. 17:282–289.

24. Weiss LA, Barrett-Connor E, von Muhlen D. Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr. 2005. 81:934–938.

25. Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL. An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J. 2007. 6:2.

26. Hogstrom M, Nordstrom P, Nordstrom A. n-3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 Study. Am J Clin Nutr. 2007. 85:803–807.

27. Corwin RL, Hartman TJ, Maczuga SA, Graubard BI. Dietary saturated fat intake is inversely associated with bone density in humans: analysis of NHANES III. J Nutr. 2006. 136:159–165.

28. Jin GB, Inoue S, Urano T, Cho S, Ouchi Y, Cyong JC. Induction of anti-metallothionein antibody and mercury treatment decreases bone mineral density in mice. Toxicol Appl Pharmacol. 2002. 185:98–110.

29. Matsuo N. Studies on the toxicity of fish oil. V. Toxicity of oxidized commercial cod-liver oil. Tokushima J Exp Med. 1961. 8:96–100.

30. Salari P, Rezaie A, Larijani B, Abdollahi M. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit. 2008. 14:RA37–RA44.

31. Salari Sharif P, Asalforoush M, Ameri F, Larijani B, Abdollahi M. The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. Age (Dordr). 2010. 32:179–186.

32. Freeman MP. Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry. 2000. 12:159–165.

33. Hardman WE. Omega-3 fatty acids to augment cancer therapy. J Nutr. 2002. 132:3508S–3512S.

34. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991. 54:438–463.

35. Kim J, Lim SY, Shin A, Sung MK, Ro J, Kang HS, et al. Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study. BMC Cancer. 2009. 9:216.

36. Kim JM, Kim TH. Changes of urinary tract after menopause and effectiveness of menopausal hormone replacement therapy. J Korean Soc Menopause. 2011. 17:136–141.

37. Behn C, Araneda OF, Llanos AJ, Celedon G, Gonzalez G. Hypoxia-related lipid peroxidation: evidences, implications and approaches. Respir Physiol Neurobiol. 2007. 158:143–150.

38. Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2006. 75:197–202.

39. Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment. BMJ. 2004. 328:30–35.

40. Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR. Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest. 1993. 91:651–660.

41. Ebbesson SO, Risica PM, Ebbesson LO, Kennish JM, Tejero ME. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project. Int J Circumpolar Health. 2005. 64:396–408.

42. Heo J, Park Y, Park HM. Dietary intake of nutrients and food in postmenopausal Korean women. J Korean Soc Menopause. 2011. 17:12–20.

43. Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006. 60:502–507.